Insights into the genotype-phenotype correlation and molecular function of SLC25A46

Alexander J. Abrams, Flavia Fontanesi, Natalie B.L. Tan, Elena Buglo, Ion J. Campeanu, Adriana P. Rebelo, Andrew J. Kornberg, Dean G. Phelan, Zornitza Stark, Stephan L Zuchner

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Recessive SLC25A46 mutations cause a spectrum of neurodegenerative disorders with optic atrophy as a core feature. We report a patient with optic atrophy, peripheral neuropathy, ataxia, but not cerebellar atrophy, who is on the mildest end of the phenotypic spectrum. By studying seven different nontruncating mutations, we found that the stability of the SLC25A46 protein inversely correlates with the severity of the disease and the patient's variant does not markedly destabilize the protein. SLC25A46 belongs to the mitochondrial transporter family, but it is not known to have transport function. Apart from this possible function, SLC25A46 forms molecular complexes with proteins involved in mitochondrial dynamics and cristae remodeling. We demonstrate that the patient's mutation directly affects the SLC25A46 interaction with MIC60. Furthermore, we mapped all of the reported substitutions in the protein onto a 3D model and found that half of them fall outside of the signature carrier motifs associated with transport function. We thus suggest that there are two distinct molecular mechanisms in SLC25A46-associated pathogenesis, one that destabilizes the protein while the other alters the molecular interactions of the protein. These results have the potential to inform clinical prognosis of such patients and indicate a pathway to drug target development.

Original languageEnglish (US)
JournalHuman Mutation
DOIs
StateAccepted/In press - Jan 1 2018

Fingerprint

Genetic Association Studies
Optic Atrophy
Proteins
Mutation
Mitochondrial Dynamics
Cerebellar Ataxia
Protein Stability
Peripheral Nervous System Diseases
Neurodegenerative Diseases
Atrophy
Pharmaceutical Preparations

Keywords

  • Ataxia
  • Mitochondria
  • Optic atrophy
  • SLC25A46

ASJC Scopus subject areas

  • Genetics
  • Genetics(clinical)

Cite this

Insights into the genotype-phenotype correlation and molecular function of SLC25A46. / Abrams, Alexander J.; Fontanesi, Flavia; Tan, Natalie B.L.; Buglo, Elena; Campeanu, Ion J.; Rebelo, Adriana P.; Kornberg, Andrew J.; Phelan, Dean G.; Stark, Zornitza; Zuchner, Stephan L.

In: Human Mutation, 01.01.2018.

Research output: Contribution to journalArticle

Abrams, Alexander J. ; Fontanesi, Flavia ; Tan, Natalie B.L. ; Buglo, Elena ; Campeanu, Ion J. ; Rebelo, Adriana P. ; Kornberg, Andrew J. ; Phelan, Dean G. ; Stark, Zornitza ; Zuchner, Stephan L. / Insights into the genotype-phenotype correlation and molecular function of SLC25A46. In: Human Mutation. 2018.
@article{00044920f86a4697833af0f0631f3d89,
title = "Insights into the genotype-phenotype correlation and molecular function of SLC25A46",
abstract = "Recessive SLC25A46 mutations cause a spectrum of neurodegenerative disorders with optic atrophy as a core feature. We report a patient with optic atrophy, peripheral neuropathy, ataxia, but not cerebellar atrophy, who is on the mildest end of the phenotypic spectrum. By studying seven different nontruncating mutations, we found that the stability of the SLC25A46 protein inversely correlates with the severity of the disease and the patient's variant does not markedly destabilize the protein. SLC25A46 belongs to the mitochondrial transporter family, but it is not known to have transport function. Apart from this possible function, SLC25A46 forms molecular complexes with proteins involved in mitochondrial dynamics and cristae remodeling. We demonstrate that the patient's mutation directly affects the SLC25A46 interaction with MIC60. Furthermore, we mapped all of the reported substitutions in the protein onto a 3D model and found that half of them fall outside of the signature carrier motifs associated with transport function. We thus suggest that there are two distinct molecular mechanisms in SLC25A46-associated pathogenesis, one that destabilizes the protein while the other alters the molecular interactions of the protein. These results have the potential to inform clinical prognosis of such patients and indicate a pathway to drug target development.",
keywords = "Ataxia, Mitochondria, Optic atrophy, SLC25A46",
author = "Abrams, {Alexander J.} and Flavia Fontanesi and Tan, {Natalie B.L.} and Elena Buglo and Campeanu, {Ion J.} and Rebelo, {Adriana P.} and Kornberg, {Andrew J.} and Phelan, {Dean G.} and Zornitza Stark and Zuchner, {Stephan L}",
year = "2018",
month = "1",
day = "1",
doi = "10.1002/humu.23639",
language = "English (US)",
journal = "Human Mutation",
issn = "1059-7794",
publisher = "Wiley-Liss Inc.",

}

TY - JOUR

T1 - Insights into the genotype-phenotype correlation and molecular function of SLC25A46

AU - Abrams, Alexander J.

AU - Fontanesi, Flavia

AU - Tan, Natalie B.L.

AU - Buglo, Elena

AU - Campeanu, Ion J.

AU - Rebelo, Adriana P.

AU - Kornberg, Andrew J.

AU - Phelan, Dean G.

AU - Stark, Zornitza

AU - Zuchner, Stephan L

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Recessive SLC25A46 mutations cause a spectrum of neurodegenerative disorders with optic atrophy as a core feature. We report a patient with optic atrophy, peripheral neuropathy, ataxia, but not cerebellar atrophy, who is on the mildest end of the phenotypic spectrum. By studying seven different nontruncating mutations, we found that the stability of the SLC25A46 protein inversely correlates with the severity of the disease and the patient's variant does not markedly destabilize the protein. SLC25A46 belongs to the mitochondrial transporter family, but it is not known to have transport function. Apart from this possible function, SLC25A46 forms molecular complexes with proteins involved in mitochondrial dynamics and cristae remodeling. We demonstrate that the patient's mutation directly affects the SLC25A46 interaction with MIC60. Furthermore, we mapped all of the reported substitutions in the protein onto a 3D model and found that half of them fall outside of the signature carrier motifs associated with transport function. We thus suggest that there are two distinct molecular mechanisms in SLC25A46-associated pathogenesis, one that destabilizes the protein while the other alters the molecular interactions of the protein. These results have the potential to inform clinical prognosis of such patients and indicate a pathway to drug target development.

AB - Recessive SLC25A46 mutations cause a spectrum of neurodegenerative disorders with optic atrophy as a core feature. We report a patient with optic atrophy, peripheral neuropathy, ataxia, but not cerebellar atrophy, who is on the mildest end of the phenotypic spectrum. By studying seven different nontruncating mutations, we found that the stability of the SLC25A46 protein inversely correlates with the severity of the disease and the patient's variant does not markedly destabilize the protein. SLC25A46 belongs to the mitochondrial transporter family, but it is not known to have transport function. Apart from this possible function, SLC25A46 forms molecular complexes with proteins involved in mitochondrial dynamics and cristae remodeling. We demonstrate that the patient's mutation directly affects the SLC25A46 interaction with MIC60. Furthermore, we mapped all of the reported substitutions in the protein onto a 3D model and found that half of them fall outside of the signature carrier motifs associated with transport function. We thus suggest that there are two distinct molecular mechanisms in SLC25A46-associated pathogenesis, one that destabilizes the protein while the other alters the molecular interactions of the protein. These results have the potential to inform clinical prognosis of such patients and indicate a pathway to drug target development.

KW - Ataxia

KW - Mitochondria

KW - Optic atrophy

KW - SLC25A46

UR - http://www.scopus.com/inward/record.url?scp=85053453739&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85053453739&partnerID=8YFLogxK

U2 - 10.1002/humu.23639

DO - 10.1002/humu.23639

M3 - Article

C2 - 30178502

AN - SCOPUS:85053453739

JO - Human Mutation

JF - Human Mutation

SN - 1059-7794

ER -